-K-E Andersson Researcher Activity Profile

Research Author Detailed Information 

K-E Andersson Publication Rate By Year

K-E Andersson has published 3 paper(s) in 1971, 3 paper(s) in 1979, 2 paper(s) in 1981, 1 paper(s) in 1982, 2 paper(s) in 1983, 2 paper(s) in 1984, 1 paper(s) in 1995, 1 paper(s) in 1998, 2 paper(s) in 2006, 16 paper(s) in 2007, 1 paper(s) in 2008, for a total of 34 research publications in total.

K-E Ke Andersson Author Information

LAST NAME: andersson

FIRST NAME: K-E

INITIALS: ke

AFFILIATION:

Papers

K-E Andersson's Publication Record

1. Treatment-resistant detrusor overactivity--underlying pharmacology and potential mechanisms. Year Published: 2006
Department of Clinical and Experimental Pharmacology, Lund University Hospital, Lund, Sweden. karl-erik.andersson@klinfarm.lu.se
2. Muscarinic receptor antagonists for overactive bladder. Year Published: 2007
Bristol Urological Institute, Southmead Hospital, Bristol, UK.
3. Treating patients with overactive bladder syndrome with antimuscarinics: heart rate considerations. Year Published: 2007
Wake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine, Winston Salem, NC, USA.
4. LUTS treatment: future treatment options. Year Published: 2007
Wake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157, USA. Karl-Eric.Andersson@med.lu.se
5. Rho-kinase and effects of Rho-kinase inhibition on the lower urinary tract. Year Published: 2007
Wake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157, USA. gchrist@wfubmc.edu
6. Phosphodiesterases (PDEs) and PDE inhibitors for treatment of LUTS. Year Published: 2007
Wake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157, USA. Karl-Eric.Andersson@med.lu.se
7. Muscarinic receptor antagonists for overactive bladder. Year Published: 2007
Bristol Urological Institute, Southmead Hospital, Bristol, UK.
8. Treating patients with overactive bladder syndrome with antimuscarinics: heart rate considerations. Year Published: 2007
Wake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine, Winston Salem, NC, USA.
9. Treatment-resistant detrusor overactivity--underlying pharmacology and potential mechanisms. Year Published: 2006
Department of Clinical and Experimental Pharmacology, Lund University Hospital, Lund, Sweden. karl-erik.andersson@klinfarm.lu.se
10. Microarray analysis of exstrophic human bladder smooth muscle. Year Published: 2007
Department of Urology, Wake Forest Institute for Regenerative Medicine, Wake Forest University, Winston-Salem, NC 27157, USA.
11. Distribution and Function of the Hydrogen Sulfide-Sensitive TRPA1 Ion Channel in Rat Urinary Bladder. Year Published: 2007
Department of Pharmacology, Drug Development and Therapeutics, University of Turku, Turku, Finland; Department of Clinical Chemistry and Pharmacology, Lund University Hospital, Lund, Sweden.
12. Simultaneous registration of intraabdominal and intravesical pressures during cystometry in conscious rats-Effects of bladder outlet obstruction and intravesical PGE(2). Year Published: 2007
Department of Clinical and Experimental Pharmacology, Lund University Hospital, Lund, Sweden.
13. LUTS treatment: future treatment options. Year Published: 2007
Wake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157, USA. Karl-Eric.Andersson@med.lu.se
14. Rho-kinase and effects of Rho-kinase inhibition on the lower urinary tract. Year Published: 2007
Wake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157, USA. gchrist@wfubmc.edu
15. Phosphodiesterases (PDEs) and PDE inhibitors for treatment of LUTS. Year Published: 2007
Wake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157, USA. Karl-Eric.Andersson@med.lu.se
16. Treating patients with overactive bladder syndrome with antimuscarinics: heart rate considerations. Year Published: 2007
Wake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine, Winston Salem, NC, USA.
17. Microarray analysis of exstrophic human bladder smooth muscle. Year Published: 2007
Department of Urology, Wake Forest Institute for Regenerative Medicine, Wake Forest University, Winston-Salem, NC 27157, USA.
18. Simultaneous registration of intraabdominal and intravesical pressures during cystometry in conscious rats--effects of bladder outlet obstruction and intravesical PGE2. Year Published: 2007
Department of Clinical and Experimental Pharmacology, Lund University Hospital, Lund, Sweden.
19. Effects of oestradiol and combined norephedrin and oestradiol treatment on female stress incontinence. Year Published: 1981
20. Localisation of neuronal nitric oxide synthase-immunoreactivity in rat and rabbit retinas. Year Published: 1995
Department of Ophthalmology, University Hospital of Lund, Sweden.
21. Nitric oxide synthase and vasopressin in rat circumventricular organs. An immunohistochemical study. Year Published: 1998
Institute of Pathology, University Hospital of Lund, Sweden. per.alm@pat.lu.se
22. Influence of acid-base changes on isolated human foetal hearts. Year Published: 1971
23. Influence of mepivacaine on isolated human foetal hearts at normal and low pH. Year Published: 1971
24. Influence of contraction rate, coronary perfusion pressure and diastolic pressure on the mechanical performance of isolated human foetal hearts. Year Published: 1971
25. Ripening of the cervix and induction of labor in patients at term by single intracervical application of prostaglandin E2 in viscous gel. Year Published: 1979
26. Ripening of the cervix by intracervical application of PGE2-gel before termination of pregnancy with dilatation and evacuation. Year Published: 1979
27. Side-effects of prostaglandin synthetase inhibitors. Year Published: 1979
28. Extrapulmonary effects of theophylline. Year Published: 1981
29. Pharmacological inhibition of uterine activity. Year Published: 1982
30. Topical and systemic glucocorticoid potencies of budesonide, beclomethasone dipropionate and prednisolone in man. Year Published: 1983
31. Aspects of inhibition of myometrial hyperactivity in primary dysmenorrhea. Year Published: 1983
32. Airway hyperreactivity, smooth muscle and calcium. Year Published: 1984
33. Pharmacokinetics of terbutaline therapy. Year Published: 1984
34. A mutation in the inner mitochondrial membrane peptidase 2-like gene (immp2l) affects mitochondrial function and impairs fertility in mice. Year Published: 2008
Institute for Regenerative Medicine and Department of Physiology and Pharmacology, Wake Forest University School of Medicine, Wake Forest University Health Sciences, Winston-Salem, North Carolina 27157.